QUICK SEARCH

The Quick Search function allows users to search for specific Guidance, Operational advice and Training based on keywords, boolean search and pre-set filters. For more in-depth search, please use the dedicated sections of this platform.

Abbreviations of TB agents

2.6 Phenotypic and genotypic DST

4.1.1 Decision pathway for Algorithm 1 – mWRD as the initial diagnostic test for TB

4.2.1 Decision pathway for Algorithm 2 – LF-LAM testing to aid in the diagnosis of TB among PLHIV

4.3.1 Decision pathway for Algorithm 3 – DST for second-line drugs for RR-TB or MDR-TB patients

4.4 Algorithm 4 – mWRD as the initial or follow-on test to detect Hr-TB

4.4.1 Decision pathway for Algorithm 4

4.5 Illustrative algorithm combinations

4.5.1 Implementing a new diagnostic algorithm

5. Suggested reading

A2.1 Information sheet: Practical considerations for implementation of the Abbott RealTime MTB and Abbott RealTime MTB RIF/INH tests

A2.2 Information sheet: Practical considerations for implementation of the BD MAX MDR-TB test

A2.3 Information sheet: Practical considerations for implementation of the Roche cobas MTB and cobas MTB-RIF/INH assays

A2.4 Information sheet: Practical considerations for implementation of the Bruker-Hain Lifesciences FluoroType MTB and FluoroType MTBDR

A2.5 Information sheet: Practical considerations for implementation of the Cepheid Xpert MTB/XDR test

A2.6 Information sheet: Practical considerations for implementation of the Nipro Genoscholar PZA-TB II assay

2.11.1 Provide free HIV and TB treatment for health workers in need, facilitating the delivery of these services in a non-stigmatizing, gendersensitive, confidential, and convenient setting even where there is no staff clinic, and/or the health worker’s own facility does not offer ART.

2.11.2 Key References and Supporting WHO Guidelines

2.11.3 Table 15: Recommendation for Statement 11